News

Dog the Bounty Hunter New Website Launches Selling CBD Infused Products Provided by CBD Global Sciences

Denver, CO – (NewMediaWire) – January 07, 2021 – CBD Global Sciences, Inc. (OTC: CBDNF) (CSE: CBDN) (Frankfurt:GS3), “CBD Global” or the “Company”), today announced the launch of the new CBD product line “Dog Unleashed CBD” and new website www.dogunleashedcbd.com.

Dog the Bounty Hunter and CBD Global Sciences have partnered to create a new CBD brand called ‘Dog Unleashed CBD’ which has been rolled out with a robust line of CBD products aimed at addressing multiple ailments in the human body with a holistic approach.  Initial sales of Dog Unleashed CBD can be found at www.dogunleashedcbd.com, an internet sales platform.  The product launch is timed to coincide with his reality TV docudrama Dog Unleashed, that is airing on a subscription-based app and will be streaming online.  

The initial product line will offer 12 different SKUs focused on multi-flavored tinctures offered in three different strengths 1000MG, 2000MG and 3500MG.  In addition to the tincture products, Dog will offer both lotions and salves and all 12 SKUs are infused with a full spectrum CBD oil that is lab tested for quality and accuracy.  All products meet established state and federal requirements of no more than 0.3% delta-9-tetrahydrocannabinol and can be sold in all 50 states.  The Company will expand the product offerings over the next two quarters in 2021 which will include CBD infused confectionary products and a hydration line to include multi flavored energy drinks.  In addition to web-based sales Dog Unleashed CBD will be distributed in conjunction with New Age Beverage into its distribution channel that boasts over 5,000 stores serviced today.

Dog the Bounty Hunter (Duane Chapman) has begun enlisting from his 6,000,000+ followers on multiple social media platforms to sign up for the airing of his new season.  

Duane ‘Dog’ Chapman stated, “I can’t tell you how grateful I am to have the opportunity to bring these products to the market and look forward to a collaborative partnership with CBD Global Sciences.  This product line is something that I have found to relieve my pain and stress and the fact that it is grown in a field, not made in a lab, is very important to me.”

Brad Wyatt, CEO of CBD Global Sciences, shared “I am very excited to have the opportunity to work with Dog and Francie on this CBD project.  Over the past year I have seen Dog in action, and I can assure you he truly cares about his fans and wants to help people feel better with a natural solution like CBD.”

ABOUT DOG UNLEASHED and DOG UNLEASHED CBD 

Dog Unleashed (launching Q2 2021) will be the fourth show that Dog has launched.  This venue has moved to online streaming and subscription-based viewing. While testing the waters on viewership Dog had over 30,000 new subscribers with just two Instagram postings about the new show (go to www.dogunleashed.com to subscribe). Viewership for the new show is expected to beat all previous records.  Past shows have set records on three different networks, A&E, CMT and WGN, of which he still holds the record for the most viewed shows in the past 15 years.  Promotional interviews that will highlight both the upcoming docudrama and the Dog Unleashed CBD have already begun and will continue with several daytime shows including Dr. Oz, Ellen, Tamron Hill, Entertainment Tonight and multiple Fox affiliates.  Most interviews will be completed virtually and through various social media platforms due to COVID -19.

ABOUT CBD GLOBAL SCIENCES INC.

CBD Global Sciences, Inc., is a vertically integrated hemp-based CBD producer and branding investment vehicle which currently owns two product categories, branded under the name AETHICS (www.aethics.com) and CANNAOIL (www.cannaoilshop.com), which include CBD Oil tinctures (liquid products), CBD capsules, CBD topicals, Hydration products and Confectionary products.  CBD Global Sciences hemp-derived CBD extracts are sold through select distributors, bricks and mortar retailers, and online.

CBD Global Sciences, through its wholly owned subsidiary, Strasburg Pharms, grows, and operates irrigated land in Colorado, that grows hemp with Colorado water, soil, sun, and nutrients and NEVER sprayed with pesticides or chemicals.  Our genetics are hand selected and maintained to present the best cannabinoid profile with extremely high CBD.  

For further information, please contact Bruce Nurse, Investor Relations, (888) 401-2239, info@cbdglobalsciences.com

 NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAS REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

 CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to future developments and the business and operations of the Corporation after the CSE listing.  Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to general business, economic, competitive, political, and social uncertainties; and delay or failure to receive board, shareholder, or regulatory approvals.  Readers should not place undue reliance on forward-looking statements.  The Corporation disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

 

Source link

Tags
Show More

Related Articles

Back to top button
Close

Get Smallcap and Microcap News, Research, Trade Alerts & MORE, all 100% FREE!

Enter your email address to get started. All 100% Free.

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on stock market & finance related, articles, news and trade alerts. Further questions please contact privacy@smallcapsdaily.com